Portuguese 
English 
Spanish 
5 min of reading 
0 comments 
Accelerated advancement in investments, scientific production, and global impact repositions China at the center of global research, surpassing the United States in key metrics and expanding influence in strategic areas, with direct reflections on innovation, economy, and the dispute for technological leadership.
In 2024, China took the top position globally in research and development spending when the comparison uses purchasing power parity, a criterion adopted to reduce distortions between national costs.
According to the Organization for Economic Cooperation and Development, the country invested the equivalent of US$ 1.03 trillion, slightly above the US$ 1.01 trillion recorded by the United States, marking a symbolic turn in the race for global scientific leadership.
Investments in research and development gain new global leadership
This surpassing is not merely the result of a one-time advancement.
-
The primate that science has called peaceful for decades has proven to be as aggressive as the chimpanzee in a study with thousands of hours of footage that debunks one of the greatest myths of primatology.
-
Xiaomi’s electric sedan traveled 4,264 kilometers in 24 hours non-stop on a track in China and set the world record for endurance for mass-produced electric cars.
-
Scientists reveal progress with batteries made from sunflower seeds that could reduce environmental impacts and spark global interest in a new generation of sustainable energy.
-
With over 3,000 horsepower and 472 km/h in Germany, the Chinese electric supercar from BYD has become the fastest electric car in the world, surpassing the Rimac Nevera by 60 km/h.
The latest figures indicate a prolonged trajectory of Chinese expansion, supported by annual increases far exceeding those observed in the United States.
In 2024, Chinese spending on R&D grew by 9.7%, nearly triple the increase of 3.4% recorded by Americans, maintaining a pace that has been narrowing the gap between the two countries in funding for science and innovation for years.
This movement gained relevance because investment in research often anticipates broader changes in the technological capacity of an economy.
By increasing resources in laboratories, universities, industrial development centers, and strategic programs, Beijing has strengthened areas considered crucial for competitiveness and economic security, such as artificial intelligence, synthetic biology, new materials, and energy.
At the same time, Chinese expansion has reduced the relative share of the United States in the global total of R&D, a trend already observed in surveys by the National Science Foundation of the USA.
Chinese growth reconfigures global scientific balance
NSF data shows that China alone accounted for 29% of global growth in research spending between 2000 and 2019.
During the same period, the country maintained an average annual growth rate of 10.6%, above that observed in the United States.
The result was a gradual change in the global distribution of scientific resources: while the American share shrank over the years, the Chinese participation advanced continuously, consolidating a funding base that now rivals the greatest scientific power of the 20th century.
Academic production and impact of citations expand protagonism
The competition, however, is not limited to the money invested.
Academic production has also begun to reflect this new balance.
In 2022, China was already the world’s largest producer of scientific publications, ahead of the United States, according to the “Science and Engineering Indicators” series from the NSF.
More recently, Clarivate reported that in 2024, China published 75% more articles indexed in the Web of Science than the Americans, a sign that quantitative leadership not only remained but expanded.
In the most prestigious research segment, the advancement was also evident.
The Nature Index had already indicated since 2023 that China was ahead of the United States among the leading countries.
The most recent tables maintained this picture and reinforced the loss of space for Western institutions in the face of China’s rise.
The quality and influence of this production are clearly visible in another sensitive indicator: the most cited articles on the planet.
Recent reports show that China accounted for 27.2% of the group formed by the top 1% of most cited studies in the world, surpassing the United States, with 24.9%.
In science, citations do not measure everything, but they help to gauge which works shape agendas, guide new research, and become references for the international academic community.
Differences by area reveal complementary strengths between China and the US
Chinese leadership, however, is not uniform across all areas.
The United States maintains a decisive weight in biology and health, fields in which universities, research hospitals, and US federal agencies remain among the most influential hubs in the world.
China, on the other hand, has gained traction especially in physical sciences, chemistry, earth sciences, and environmental areas, segments in which the volume of articles, presence in selective journals, and the influence of cutting-edge work have rapidly increased.
Patents and technological innovation reinforce Chinese leadership
Another important gauge of this transformation appears in the international patent system.
Since 2019, China has led international applications filed under the Patent Cooperation Treaty.
In 2023, the country filed 69,610 applications, ahead of the United States, with 55,678, and Japan, with 48,879.
The data shows that the Chinese origin accounted for more than a quarter of the global total, reinforcing the country’s ability to convert research into technological assets with potential economic application.
Public funding can consolidate turnaround by the end of the decade
The trend extends to state funding.
Projections indicate that China could become, within two years, the largest public funder of science on the planet.
The estimate reflects the continuity of Chinese government contributions and contrasts with a more stable scenario for the public research budget in the United States.
This potential advancement in public funding helps explain why the dispute between Beijing and Washington has gained a more structural dimension.
In the United States, the strength of the scientific system continues to be anchored in elite universities, the business innovation ecosystem, the attraction of international talent, and the tradition of leadership in biomedical and computational fields.
China, in turn, combines long-term state planning, accelerated expansion of STEM education, growth of research infrastructure, and an explicit strategy to reduce external technological dependencies.
The shift in position indicates that the geography of science has become more concentrated in Asia and that the ability to set research priorities, establish technological standards, and influence global industrial chains increasingly depends on decisions made in Beijing.
The most eloquent data of this turnaround is that China no longer appears merely as an emerging power in scientific production, but as the country that combines financial scale, academic volume, bibliometric impact, and patent performance sufficient to compete for the center of the global science and innovation system.
Seja o primeiro a reagir!